The Latest Breaking News from Oak Street Health

CVS Health is plunging deeper into providing primary care with an approximately $10.6 billion deal to acquire Oak Street Health

"Combining Oak Street Health's platform with CVS Health's unmatched reach will create the premier value-based primary care solution," said CVS CEO Karen Lynch.

New reports suggest CVS is prepared to pay as much as $10.5 billion for the Chicago-based primary care center operator.

Stock futures edge higher as Treasury yields steady; Powell speech in focus as markets embrace higher Fed rates; Oak Street Health soars on new CVS takeover report; Bed Bath & Beyond plummets as retailer plans $1 billion capital raise and Boeing to cut 2,000 jobs as U.S. Corporate layoffs escalate.

CVS Health is reportedly exploring a $10 billion deal to buy Oak Street Health. Will that make CVS stock a buy?

CVS is reportedly looking to expand its health-care footprint with the $10 billion purchase of primary-care-center operator Oak Street Health.

Stock futures slip lower on hawkish Fed signals; Powell speech in focus as rate bets test tightening path; Pfizer may sell Covid treatment in China through local partner; Oak Street Health soars on $10 billion CVS takeover report and Microsoft said to eye $10 billion OpenAI investment.

Upgrades

Over the past 3 months, 5 analysts have published their opinion on Oak Street Health (NYSE:OSH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

In September, AARP, the giant organization for older Americans, agreed to promote a burgeoning chain of medical clinics called Oak Street Health, which has opened more than 100 primary care outlets in nearly two dozen states.

Analysts have provided the following ratings for Oak Street Health (NYSE:OSH) within the last quarter: